Goodpasture's disease in a patient with advanced lung cancer treated with nivolumab: An autopsy case report

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Naoki TakahashiEiji Takeuchi

Abstract

Nivolumab, an anti-programmed death-1 immune checkpoint inhibitor (ICI), is now widely used to treat numerous cancers. Although most adverse effects related to ICIs are controllable, fulminant immune-related adverse events can occur. A 74-year-old patient with non-small-cell lung cancer was treated with nivolumab as a second-line treatment. After 8 cycles, acute kidney injury with macroscopic hematuria appeared, followed by diffuse ground-glass opacities with hemoptysis. Since the clinical course suggested Goodpasture's disease, methylprednisolone pulse therapy and plasma exchange were started. Later, it was confirmed that the serum anti-glomerular basement membrane antibody was positive. However, the patient died 35 days after admission due to respiratory failure, and an autopsy showed crescentic glomerulonephritis and massive alveolar hemorrhage which were compatible with Goodpasture's disease. Our case provides a possible link between nivolumab and lethal Goodpasture's disease.

References

Jan 6, 2011·Clinical Reviews in Allergy & Immunology·Andrew L ChanTimothy E Albertson
Oct 4, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·John ReynoldsCharles D Pusey
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
May 4, 2016·Immunotherapy·Ryan GentzlerOsama E Rahma
Jun 11, 2016·Kidney International·Frank B CortazarDavid E Leaf
Jan 12, 2017·American Journal of Nephrology·Rimda WanchooUNKNOWN Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors

❮ Previous
Next ❯

Citations

Jan 14, 2020·Nephrology·Sophie ChattertonMuh G Wong
Jul 16, 2019·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Roman Shingarev, Ilya G Glezerman
Jan 12, 2021·KI Reports·Abhijat KitchluRimda Wanchoo
Jun 25, 2020·Respiratory Medicine Case Reports·Vickie R ShannonSaadia A Faiz
Oct 13, 2021·Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace·Vasiliki Epameinondas GeorgakopoulouXanthi Tsiafaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.